Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: A case series
- PMID: 34368412
- PMCID: PMC8326725
- DOI: 10.1016/j.gore.2021.100833
Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: A case series
Abstract
We describe outcomes of patients with suspected placenta percreta treated with placental uterine artery embolization (P-UAE) followed by delayed hysterectomy. This is a prospective case series of subjects from 2005 to 2018 with suspected placenta percreta who underwent P-UAE at the time of cesarean delivery followed by delayed hysterectomy. Both scheduled and unscheduled surgical cases were included. Maternal characteristics, surgical approaches, intra- and postoperative outcomes were abstracted from medical records. In total, twenty-two subjects were included. Median (interquartile range, IQR) delivery gestational age was 34.6 (31.9, 35.7) weeks, occurring as scheduled in 17 (77.3%) subjects and unscheduled in 5 (22.7%). Delayed hysterectomy was performed as scheduled in 17 (77.3%) subjects at a median (IQR) 40.5 (38.0, 44.0) days after delivery, and 5 (22.7%) subjects had a hysterectomy prior to scheduled date, median (IQR) 27.0 (17.0, 35.0) days after delivery. Indications for the 5 unscheduled hysterectomies included bleeding (n = 3) and suspected endometritis (n = 2). Three subjects (13.6%) received a blood transfusion (1, 3, 3 units) during delivery, and 7 (31.8%) were transfused during delayed hysterectomy (median [IQR] 2 [1,3] units). Three (13.6%) subjects had bladder resection at the time of hysterectomy; 1 (4.5%) had an unintentional cystotomy and 1 (4.5%) had a ureteral injury. P-UAE followed by delayed hysterectomy appears to be a safe and feasible, although appropriate patient selection and close surveillance are imperative, as 22.7% of patients underwent unscheduled hysterectomy.
Keywords: Massive transfusion protocol; Morbidly adherent placenta; Multidisciplinary team; Placenta accreta spectrum; Postpartum hemorrhage; Uterine artery embolization.
© 2021 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy.Am J Perinatol. 2022 Oct;29(14):1503-1513. doi: 10.1055/s-0042-1754321. Epub 2022 Aug 16. Am J Perinatol. 2022. PMID: 35973741 Free PMC article.
-
Placenta percreta - a management dilemma: an institutional experience and review of the literature.J Turk Ger Gynecol Assoc. 2020 Dec 4;21(4):228-235. doi: 10.4274/jtgga.galenos.2020.2020.0106. J Turk Ger Gynecol Assoc. 2020. PMID: 33274037 Free PMC article.
-
Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.Gynecol Oncol Res Pract. 2017 Aug 22;4:11. doi: 10.1186/s40661-017-0049-6. eCollection 2017. Gynecol Oncol Res Pract. 2017. PMID: 28852530 Free PMC article.
-
Placenta accreta spectrum: accreta, increta, and percreta.Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402. doi: 10.1016/j.ogc.2015.01.014. Obstet Gynecol Clin North Am. 2015. PMID: 26002174 Review.
-
Management of placenta percreta: a review of published cases.Acta Obstet Gynecol Scand. 2014 Feb;93(2):138-43. doi: 10.1111/aogs.12295. Epub 2013 Nov 25. Acta Obstet Gynecol Scand. 2014. PMID: 24266548 Review.
Cited by
-
Comparison of One-Stage and Two-Stage Intraoperative Uterine Artery Embolization during Cesarean Delivery for Placenta Accreta: Report of Two Clinical Cases at a Tertiary Referral Medical Center.Healthcare (Basel). 2022 Apr 22;10(5):774. doi: 10.3390/healthcare10050774. Healthcare (Basel). 2022. PMID: 35627911 Free PMC article.
-
Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy.Am J Perinatol. 2022 Oct;29(14):1503-1513. doi: 10.1055/s-0042-1754321. Epub 2022 Aug 16. Am J Perinatol. 2022. PMID: 35973741 Free PMC article.
-
A Review of Conservative Surgical Approaches for Managing Placenta Accreta Spectrum.Cureus. 2025 Mar 31;17(3):e81551. doi: 10.7759/cureus.81551. eCollection 2025 Mar. Cureus. 2025. PMID: 40314053 Free PMC article. Review.
References
-
- ACOG Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132(6):1519–1521. - PubMed
-
- D'Souza D.L., Kingdom J.C., Amsalem H., Beecroft J.R., Windrim R.C., Kachura J.R. Conservative Management of Invasive Placenta Using Combined Prophylactic Internal Iliac Artery Balloon Occlusion and Immediate Postoperative Uterine Artery Embolization. Can. Assoc. Radiol. J. 2015;66(2):179–184. - PubMed
-
- Einerson B.D., Comstock J., Silver R.M., Branch D.W., Woodward P.J., Kennedy A. Placenta Accreta Spectrum Disorder: Uterine Dehiscence Not Placental Invasion. Obstet Gynecol. 2020;135(5):1104–1111. - PubMed
-
- Fox K.A., Shamshirsaz A.A., Carusi D., Secord A.A., Lee P., Turan O.M., Huls C., Abuhamad A., Simhan H., Barton J., Wright J., Silver R., Belfort M.A. Conservative management of morbidly adherent placenta: expert review. Am. J. Obstet. Gynecol. 2015;213(6):755–760. - PubMed
-
- Izbizky G., Meller C., Grasso M., Velazco A., Peralta O., Otaño L., Garcia-Monaco R. Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta. J. Vasc. Interv. Radiol. 2015;26(2):162–169. - PubMed
Publication types
LinkOut - more resources
Full Text Sources